The authors found concurrent growth in pharmacy benefit manager market concentration and worsening of patient access measures across states from 2016 to 2025.
|Articles|December 1, 2002
Supplements and Featured Publications
- Analgesics and Cardioprotection: Balancing CV Benefits and GI Risks
- Volume 8
- Issue 22 Suppl
Update on Aspirin in the Treatment and Prevention of Cardiovascular Disease
Author(s)Charles H. Hennekens, MD, DrPH
Advertisement
Articles in this issue
almost 24 years ago
Participating Facultyalmost 24 years ago
Gastrointestinal Safety of Low-Dose AspirinAdvertisement
Related to this article
Advertisement
Advertisement
Trending on AJMC
1
Real-World Cohort Ties JAK Inhibitors in Alopecia Areata to Menstrual Side Effects
2
Phase 3 Trial Tests Ensifentrine for COPD Exacerbation Prevention
3
Trends in Pharmacy Benefit Manager Market Dynamics, 2016-2025
4
Tarlatamab Plus Durvalumab Cuts Risk of Death by 58% as First-Line Maintenance in ES-SCLC
5